Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Intersect ENT, Inc.
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
January 25, 2022
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Reports Third Quarter 2021 Financial Results
November 02, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Reports Second Quarter 2021 Financial Results
August 06, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT to Report Second Quarter 2021 Financial Results on August 6
July 23, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
July 22, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
May 20, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Reports First Quarter 2021 Financial Results
May 10, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT to Participate at Upcoming Investor Conferences
May 07, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Announces Appointment of New Vice President of Sales
May 04, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement
April 29, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
April 29, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Intersect ENT to Report First Quarter 2021 Financial Results
April 20, 2021
From
Intersect ENT, Inc.
Via
Business Wire
Tickers
XENT
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.